Gesundheit
Branchen-Index
Biotechnologie (Forschung)-Aktien
Vollständige Übersicht aller 399 börsennotierten Unternehmen der Branche Biotechnologie (Forschung). Vergleichen Sie Marktkapitalisierung, Bewertungs-KGV, Dividendenrendite und Insider-Scores im direkten Wettbewerbsvergleich.
Unternehmen
399
100 % erfasst
Gesamtkapitalisierung
2,52 Bio. $
Gesamtwert
Median-KGV
6,1
Bewertungsniveau
Ø Insider-Score
39,7
Conviction-Skala 0–100
| # | Unternehmen / Ticker | Marktkapitalisierung | Letzter Kurs | KGV | Dividende | Insider-Score | Analyse |
|---|---|---|---|---|---|---|---|
| 1 | AKTX Akari Therapeutics Plc | 1,51 Bio. $ Mega Cap | 8,39 $ | — | — | 40 | Details › |
| 2 | TMO THERMO FISHER SCIENTIFIC INC. | 247,4 Mrd. $ Mega Cap | 656,58 $ | 36,9 | 0,3 % | 59 | Details › |
| 3 | AVXL ANAVEX LIFE SCIENCES CORP. | 178,8 Mrd. $ Mega Cap | 1,60 $ | — | — | 34 | Details › |
| 4 | LGVN Longeveron Inc. | 47,5 Mrd. $ Mega Cap | 2,35 $ | — | — | 5 | Details › |
| 5 | RVMD Revolution Medicines, Inc. | 45,8 Mrd. $ Mega Cap | 199,87 $ | — | — | 54 | Details › |
| 6 | NVZMF NOVOZYMES AS/FI | 30,4 Mrd. $ Mega Cap | 65,11 $ | 46,2 | 0,3 % | — | Details › |
| 7 | ROIV Roivant Sciences Ltd. | 27,8 Mrd. $ Mega Cap | 35,53 $ | — | — | 42 | Details › |
| 8 | BNTX BioNTech SE | 24,9 Mrd. $ Mega Cap | 95,73 $ | — | — | 45 | Details › |
| 9 | GMAB GENMAB A/S | 21,2 Mrd. $ Mega Cap | 37,80 $ | 22,4 | — | 62 | Details › |
| 10 | BBIO BridgeBio Pharma, Inc. | 12,8 Mrd. $ Mega Cap | 66,96 $ | — | — | 33 | Details › |
| 11 | HALO HALOZYME THERAPEUTICS, INC. | 12,4 Mrd. $ Mega Cap | 109,72 $ | 42,9 | — | 54 | Details › |
| 12 | TECH BIO-TECHNE Corp | 11,4 Mrd. $ Mega Cap | 72,43 $ | 62,4 | 0,4 % | 58 | Details › |
| 13 | TWST Twist Bioscience Corp | 10,7 Mrd. $ Mega Cap | 166,97 $ | — | — | 41 | Details › |
| 14 | IBRX ImmunityBio, Inc. | 10,2 Mrd. $ Mega Cap | 9,69 $ | — | — | 33 | Details › |
| 15 | AXSM Axsome Therapeutics, Inc. | 10,0 Mrd. $ Large Cap | 174,34 $ | — | — | 31 | Details › |
| 16 | KRYS Krystal Biotech, Inc. | 9,4 Mrd. $ Large Cap | 326,81 $ | 47,1 | — | 61 | Details › |
| 17 | PCVX Vaxcyte, Inc. | 9,3 Mrd. $ Large Cap | 66,70 $ | — | — | 41 | Details › |
| 18 | PTGX Protagonist Therapeutics, Inc | 9,1 Mrd. $ Large Cap | 138,69 $ | — | — | 33 | Details › |
| 19 | KYMR Kymera Therapeutics, Inc. | 9,0 Mrd. $ Large Cap | 105,98 $ | — | — | 41 | Details › |
| 20 | PRAX Praxis Precision Medicines, Inc. | 8,9 Mrd. $ Large Cap | 280,14 $ | — | — | 29 | Details › |
| 21 | SYRE Spyre Therapeutics, Inc. | 8,6 Mrd. $ Large Cap | 80,11 $ | — | — | 32 | Details › |
| 22 | CGON CG Oncology, Inc. | 6,3 Mrd. $ Large Cap | 63,64 $ | — | — | 37 | Details › |
| 23 | SRRK Scholar Rock Holding Corp | 6,1 Mrd. $ Large Cap | 42,45 $ | — | — | 49 | Details › |
| 24 | GOSS Gossamer Bio, Inc. | 5,7 Mrd. $ Large Cap | 10,78 $ | — | — | 20 | Details › |
| 25 | ORKA Oruka Therapeutics, Inc. | 5,7 Mrd. $ Large Cap | 80,18 $ | — | — | 51 | Details › |
| 26 | KOD Kodiak Sciences Inc. | 5,6 Mrd. $ Large Cap | 92,34 $ | — | — | 48 | Details › |
| 27 | COGT Cogent Biosciences, Inc. | 5,6 Mrd. $ Large Cap | 30,38 $ | — | — | 47 | Details › |
| 28 | DNTH Dianthus Therapeutics, Inc. /DE/ | 5,3 Mrd. $ Large Cap | 85,40 $ | — | — | 35 | Details › |
| 29 | CRSP CRISPR Therapeutics AG | 5,3 Mrd. $ Large Cap | 54,00 $ | — | — | 51 | Details › |
| 30 | XENE Xenon Pharmaceuticals Inc. | 5,1 Mrd. $ Large Cap | 36,57 $ | — | — | 45 | Details › |
| 31 | EWTX Edgewise Therapeutics, Inc. | 4,8 Mrd. $ Large Cap | 40,02 $ | — | — | 44 | Details › |
| 32 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | 4,5 Mrd. $ Large Cap | 12,96 $ | — | — | 36 | Details › |
| 33 | ABCL AbCellera Biologics Inc. | 4,1 Mrd. $ Large Cap | 13,15 $ | — | — | 21 | Details › |
| 34 | CELC Celcuity Inc. | 4,0 Mrd. $ Large Cap | 71,25 $ | — | — | 41 | Details › |
| 35 | RLAY Relay Therapeutics, Inc. | 3,8 Mrd. $ Large Cap | 18,74 $ | — | — | 42 | Details › |
| 36 | ELVN Enliven Therapeutics, Inc. | 3,8 Mrd. $ Large Cap | 42,39 $ | — | — | 43 | Details › |
| 37 | TNGX Tango Therapeutics, Inc. | 3,8 Mrd. $ Large Cap | 21,90 $ | — | — | 46 | Details › |
| 38 | IDYA IDEAYA Biosciences, Inc. | 3,6 Mrd. $ Large Cap | 36,63 $ | — | — | 49 | Details › |
| 39 | LEGN Legend Biotech Corp | 3,4 Mrd. $ Large Cap | 18,72 $ | — | — | 58 | Details › |
| 40 | DYN Dyne Therapeutics, Inc. | 3,3 Mrd. $ Large Cap | 15,40 $ | — | — | 48 | Details › |
| 41 | DBVT DBV Technologies S.A. | 3,2 Mrd. $ Large Cap | 9,98 $ | — | — | 26 | Details › |
| 42 | DNLI Denali Therapeutics Inc. | 3,2 Mrd. $ Large Cap | 19,28 $ | — | — | 40 | Details › |
| 43 | RGC Regencell Bioscience Holdings Ltd | 3,2 Mrd. $ Large Cap | 7,35 $ | — | — | 40 | Details › |
| 44 | VKTX Viking Therapeutics, Inc. | 3,0 Mrd. $ Large Cap | 28,38 $ | — | — | 32 | Details › |
| 45 | RCUS Arcus Biosciences, Inc. | 3,0 Mrd. $ Large Cap | 24,28 $ | — | — | 40 | Details › |
| 46 | CLDX Celldex Therapeutics, Inc. | 2,9 Mrd. $ Large Cap | 31,01 $ | — | — | 31 | Details › |
| 47 | PGEN PRECIGEN, INC. | 2,8 Mrd. $ Large Cap | 7,55 $ | — | — | 39 | Details › |
| 48 | SCNI Scinai Immunotherapeutics Ltd. | 2,6 Mrd. $ Large Cap | 1,22 $ | — | — | 51 | Details › |
| 49 | MBX MBX Biosciences, Inc. | 2,6 Mrd. $ Large Cap | 56,92 $ | — | — | 45 | Details › |
| 50 | IRON Disc Medicine, Inc. | 2,5 Mrd. $ Large Cap | 61,65 $ | — | — | 35 | Details › |
| 51 | BEAM Beam Therapeutics Inc. | 2,5 Mrd. $ Large Cap | 25,23 $ | — | — | 39 | Details › |
| 52 | NRIX Nurix Therapeutics, Inc. | 2,4 Mrd. $ Large Cap | 22,60 $ | — | — | 46 | Details › |
| 53 | QURE uniQure N.V. | 2,4 Mrd. $ Large Cap | 23,06 $ | — | — | 43 | Details › |
| 54 | SLS SELLAS Life Sciences Group, Inc. | 2,4 Mrd. $ Large Cap | 11,34 $ | — | — | 37 | Details › |
| 55 | MLYS Mineralys Therapeutics, Inc. | 2,4 Mrd. $ Large Cap | 21,95 $ | — | — | 31 | Details › |
| 56 | VERA Vera Therapeutics, Inc. | 2,4 Mrd. $ Large Cap | 29,42 $ | — | — | 47 | Details › |
| 57 | VRDN Viridian Therapeutics, Inc.\DE | 2,3 Mrd. $ Large Cap | 18,22 $ | — | — | 31 | Details › |
| 58 | NKTR NEKTAR THERAPEUTICS | 2,2 Mrd. $ Large Cap | 39,91 $ | — | — | 35 | Details › |
| 59 | VCEL Vericel Corp | 2,0 Mrd. $ Large Cap | 40,05 $ | 125,5 | — | 64 | Details › |
| 60 | BHVN Biohaven Ltd. | 2,0 Mrd. $ Large Cap | 12,08 $ | — | — | 42 | Details › |
| 61 | RXRX RECURSION PHARMACEUTICALS, INC. | 2,0 Mrd. $ Mid Cap | 4,63 $ | — | — | 41 | Details › |
| 62 | XNCR Xencor Inc | 1,9 Mrd. $ Mid Cap | 24,36 $ | — | — | 36 | Details › |
| 63 | NUVB Nuvation Bio Inc. | 1,9 Mrd. $ Mid Cap | 4,88 $ | — | — | 46 | Details › |
| 64 | ZBIO Zenas BioPharma, Inc. | 1,8 Mrd. $ Mid Cap | 26,94 $ | — | — | 37 | Details › |
| 65 | FTRE Fortrea Holdings Inc. | 1,8 Mrd. $ Mid Cap | 20,78 $ | — | — | 47 | Details › |
| 66 | ZYME Zymeworks Inc. | 1,8 Mrd. $ Mid Cap | 25,65 $ | — | — | 46 | Details › |
| 67 | MESO MESOBLAST LTD | 1,8 Mrd. $ Mid Cap | 13,61 $ | — | — | 40 | Details › |
| 68 | VIR Vir Biotechnology, Inc. | 1,8 Mrd. $ Mid Cap | 11,60 $ | — | — | 44 | Details › |
| 69 | GENB Generate Biomedicines, Inc. | 1,8 Mrd. $ Mid Cap | 13,83 $ | — | — | 36 | Details › |
| 70 | CMPS COMPASS Pathways plc | 1,8 Mrd. $ Mid Cap | 11,56 $ | — | — | 44 | Details › |
| 71 | AZTA Azenta, Inc. | 1,7 Mrd. $ Mid Cap | 39,35 $ | — | 0,3 % | 46 | Details › |
| 72 | ABSI Absci Corp | 1,6 Mrd. $ Mid Cap | 10,27 $ | — | — | 48 | Details › |
| 73 | RAPP Rapport Therapeutics, Inc. | 1,6 Mrd. $ Mid Cap | 31,15 $ | — | — | 37 | Details › |
| 74 | NTLA Intellia Therapeutics, Inc. | 1,6 Mrd. $ Mid Cap | 12,37 $ | — | — | 44 | Details › |
| 75 | GHRS GH Research PLC | 1,6 Mrd. $ Mid Cap | 21,52 $ | — | — | 48 | Details › |
| 76 | TSHA Taysha Gene Therapies, Inc. | 1,6 Mrd. $ Mid Cap | 4,39 $ | — | — | 47 | Details › |
| 77 | SLN Silence Therapeutics plc | 1,6 Mrd. $ Mid Cap | 9,83 $ | — | — | 45 | Details › |
| 78 | SEPN Septerna, Inc. | 1,6 Mrd. $ Mid Cap | 36,45 $ | — | — | 65 | Details › |
| 79 | IMCR Immunocore Holdings plc | 1,5 Mrd. $ Mid Cap | 29,55 $ | — | — | 32 | Details › |
| 80 | COAG Hemab Therapeutics Holdings, Inc. | 1,5 Mrd. $ Mid Cap | 29,69 $ | — | — | 38 | Details › |
| 81 | ANAB ANAPTYSBIO, INC | 1,5 Mrd. $ Mid Cap | 47,89 $ | — | — | 52 | Details › |
| 82 | INBX Inhibrx Biosciences, Inc. | 1,4 Mrd. $ Mid Cap | 93,41 $ | — | — | 39 | Details › |
| 83 | MAZE Maze Therapeutics, Inc. | 1,3 Mrd. $ Mid Cap | 26,43 $ | — | — | 36 | Details › |
| 84 | TYRA Tyra Biosciences, Inc. | 1,3 Mrd. $ Mid Cap | 20,24 $ | — | — | 28 | Details › |
| 85 | ORIC Oric Pharmaceuticals, Inc. | 1,3 Mrd. $ Mid Cap | 11,98 $ | — | — | 28 | Details › |
| 86 | OMER OMEROS CORP | 1,2 Mrd. $ Mid Cap | 18,51 $ | — | — | 28 | Details › |
| 87 | VOR Vor Biopharma Inc. | 1,2 Mrd. $ Mid Cap | 18,31 $ | — | — | 35 | Details › |
| 88 | BCAX Bicara Therapeutics Inc. | 1,2 Mrd. $ Mid Cap | 16,75 $ | — | — | 40 | Details › |
| 89 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | 1,2 Mrd. $ Mid Cap | 7,85 $ | — | — | 51 | Details › |
| 90 | REPL Replimune Group, Inc. | 1,1 Mrd. $ Mid Cap | 13,25 $ | — | — | 45 | Details › |
| 91 | MGTX MeiraGTx Holdings plc | 1,1 Mrd. $ Mid Cap | 10,60 $ | — | — | 34 | Details › |
| 92 | LBRX LB PHARMACEUTICALS INC | 1,1 Mrd. $ Mid Cap | 34,26 $ | — | — | 25 | Details › |
| 93 | JANX Janux Therapeutics, Inc. | 1,1 Mrd. $ Mid Cap | 16,79 $ | — | — | 31 | Details › |
| 94 | IMTX Immatics N.V. | 1,1 Mrd. $ Mid Cap | 7,50 $ | — | — | 28 | Details › |
| 95 | TRAX First Tracks Biotherapeutics, Inc. | 1,0 Mrd. $ Mid Cap | 32,30 $ | — | — | 76 | Details › |
| 96 | JBIO Jade Biosciences, Inc. | 999,2 Mio. $ Mid Cap | 13,41 $ | — | — | 31 | Details › |
| 97 | AKTS Aktis Oncology, Inc. | 988,6 Mio. $ Mid Cap | 18,47 $ | — | — | 66 | Details › |
| 98 | ABUS Arbutus Biopharma Corp | 962,2 Mio. $ Mid Cap | 4,48 $ | — | — | 41 | Details › |
| 99 | MLTX MoonLake Immunotherapeutics | 921,6 Mio. $ Mid Cap | 10,95 $ | — | — | 41 | Details › |
| 100 | SANA Sana Biotechnology, Inc. | 888,2 Mio. $ Mid Cap | 2,75 $ | — | — | 43 | Details › |
| 101 | GRML Greenland Mines Ltd | 883,9 Mio. $ Mid Cap | 6,38 $ | — | 296,5 % | 32 | Details › |
| 102 | RIGL RIGEL PHARMACEUTICALS INC | 862,0 Mio. $ Mid Cap | 46,11 $ | 2,4 | — | 75 | Details › |
| 103 | CADL Candel Therapeutics, Inc. | 860,8 Mio. $ Mid Cap | 9,87 $ | — | — | 33 | Details › |
| 104 | SLBT SL Science Holding Ltd | 854,9 Mio. $ Mid Cap | 1,52 $ | — | — | — | Details › |
| 105 | ODTX Odyssey Therapeutics, Inc. | 839,2 Mio. $ Mid Cap | 19,80 $ | — | — | — | Details › |
| 106 | ARDX ARDELYX, INC. | 828,6 Mio. $ Mid Cap | 3,31 $ | — | — | 40 | Details › |
| 107 | IMMX Immix Biopharma, Inc. | 823,5 Mio. $ Mid Cap | 9,64 $ | — | — | 41 | Details › |
| 108 | ACRS Aclaris Therapeutics, Inc. | 822,9 Mio. $ Mid Cap | 3,70 $ | — | — | 26 | Details › |
| 109 | OLMA Olema Pharmaceuticals, Inc. | 792,8 Mio. $ Mid Cap | 7,92 $ | — | — | 28 | Details › |
| 110 | AVTX Avalo Therapeutics, Inc. | 775,2 Mio. $ Mid Cap | 13,59 $ | — | — | 29 | Details › |
| 111 | DSGN Design Therapeutics, Inc. | 765,4 Mio. $ Mid Cap | 11,97 $ | — | — | 52 | Details › |
| 112 | ANL Adlai Nortye Group Ltd. | 738,4 Mio. $ Mid Cap | 14,46 $ | — | — | 45 | Details › |
| 113 | FDMT 4D Molecular Therapeutics, Inc. | 730,9 Mio. $ Mid Cap | 12,56 $ | — | — | 42 | Details › |
| 114 | SLDB Solid Biosciences Inc. | 726,1 Mio. $ Mid Cap | 6,92 $ | — | — | 33 | Details › |
| 115 | AURA Aura Biosciences, Inc. | 700,8 Mio. $ Mid Cap | 6,17 $ | — | — | 54 | Details › |
| 116 | OABI OmniAb, Inc. | 676,2 Mio. $ Mid Cap | 4,35 $ | — | 53,8 % | 59 | Details › |
| 117 | IMMP IMMUTEP Ltd | 662,0 Mio. $ Mid Cap | 4,34 $ | — | — | 40 | Details › |
| 118 | STTK Shattuck Labs, Inc. | 639,4 Mio. $ Mid Cap | 5,86 $ | — | — | 44 | Details › |
| 119 | MNPR Monopar Therapeutics | 632,5 Mio. $ Mid Cap | 79,57 $ | — | — | 30 | Details › |
| 120 | CLYM Climb Bio, Inc. | 625,1 Mio. $ Mid Cap | 10,68 $ | — | — | 37 | Details › |
| 121 | ALMS ALUMIS INC. | 624,4 Mio. $ Mid Cap | 6,93 $ | — | — | 23 | Details › |
| 122 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 621,0 Mio. $ Mid Cap | 2,70 $ | — | — | 33 | Details › |
| 123 | VALN Valneva SE | 603,5 Mio. $ Mid Cap | 5,86 $ | — | — | 37 | Details › |
| 124 | CBIO CRESCENT BIOPHARMA, INC. | 598,9 Mio. $ Mid Cap | 13,57 $ | — | — | 37 | Details › |
| 125 | PHAT Phathom Pharmaceuticals, Inc. | 590,1 Mio. $ Mid Cap | 6,78 $ | — | — | 32 | Details › |
| 126 | DNA Ginkgo Bioworks Holdings, Inc. | 569,8 Mio. $ Mid Cap | 12,41 $ | — | — | 32 | Details › |
| 127 | CAPR CAPRICOR THERAPEUTICS, INC. | 569,0 Mio. $ Mid Cap | 7,75 $ | — | — | 4 | Details › |
| 128 | NGNE Neurogene Inc. | 567,8 Mio. $ Mid Cap | 25,45 $ | — | — | 51 | Details › |
| 129 | ALLO Allogene Therapeutics, Inc. | 564,6 Mio. $ Mid Cap | 1,46 $ | — | — | 45 | Details › |
| 130 | CTMX CytomX Therapeutics, Inc. | 558,2 Mio. $ Mid Cap | 2,56 $ | — | — | 33 | Details › |
| 131 | EVO Evotec SE | 554,1 Mio. $ Mid Cap | 1,63 $ | — | — | 53 | Details › |
| 132 | DRUG BRIGHT MINDS BIOSCIENCES INC. | 526,1 Mio. $ Mid Cap | 48,25 $ | — | — | 38 | Details › |
| 133 | PRME Prime Medicine, Inc. | 517,2 Mio. $ Mid Cap | 3,50 $ | — | — | 26 | Details › |
| 134 | ALT Altimmune, Inc. | 516,3 Mio. $ Mid Cap | 2,67 $ | — | — | 37 | Details › |
| 135 | ARVN ARVINAS, INC. | 513,4 Mio. $ Mid Cap | 7,31 $ | — | — | 49 | Details › |
| 136 | AUTL Autolus Therapeutics plc | 487,7 Mio. $ Mid Cap | 1,79 $ | — | — | 42 | Details › |
| 137 | ASMB ASSEMBLY BIOSCIENCES, INC. | 483,0 Mio. $ Mid Cap | 22,18 $ | — | — | 45 | Details › |
| 138 | PBYI PUMA BIOTECHNOLOGY, INC. | 481,5 Mio. $ Mid Cap | 9,50 $ | 15,6 | — | 70 | Details › |
| 139 | RGNX REGENXBIO Inc. | 481,5 Mio. $ Mid Cap | 7,45 $ | — | — | 31 | Details › |
| 140 | TECX Tectonic Therapeutic, Inc. | 480,7 Mio. $ Mid Cap | 22,41 $ | — | — | 34 | Details › |
| 141 | OVID Ovid Therapeutics Inc. | 478,9 Mio. $ Mid Cap | 2,37 $ | — | — | 42 | Details › |
| 142 | MPLT MapLight Therapeutics, Inc. | 461,4 Mio. $ Mid Cap | 9,69 $ | — | — | 47 | Details › |
| 143 | ZURA Zura Bio Ltd | 456,7 Mio. $ Mid Cap | 3,96 $ | — | — | 40 | Details › |
| 144 | ARCT Arcturus Therapeutics Holdings Inc. | 452,4 Mio. $ Mid Cap | 13,00 $ | — | — | 30 | Details › |
| 145 | TKNO Alpha Teknova, Inc. | 431,7 Mio. $ Mid Cap | 8,75 $ | — | — | 52 | Details › |
| 146 | RLMD RELMADA THERAPEUTICS, INC. | 420,7 Mio. $ Mid Cap | 3,28 $ | — | — | 56 | Details › |
| 147 | CTNM Contineum Therapeutics, Inc. | 409,8 Mio. $ Mid Cap | 12,65 $ | — | — | 55 | Details › |
| 148 | AGMB AgomAb Therapeutics NV | 403,0 Mio. $ Mid Cap | 8,70 $ | — | — | 26 | Details › |
| 149 | DMAC DiaMedica Therapeutics Inc. | 402,7 Mio. $ Mid Cap | 8,13 $ | — | — | 44 | Details › |
| 150 | EDIT Editas Medicine, Inc. | 401,7 Mio. $ Mid Cap | 2,73 $ | — | — | 43 | Details › |
| 151 | INDP Indaptus Therapeutics, Inc. | 401,2 Mio. $ Mid Cap | 2,59 $ | — | — | 13 | Details › |
| 152 | PRTA PROTHENA CORP PUBLIC LTD CO | 396,1 Mio. $ Mid Cap | 8,02 $ | — | — | 47 | Details › |
| 153 | SRZN Surrozen, Inc./DE | 394,2 Mio. $ Mid Cap | 26,37 $ | — | — | 38 | Details › |
| 154 | CCCC C4 Therapeutics, Inc. | 390,1 Mio. $ Mid Cap | 2,88 $ | — | — | 52 | Details › |
| 155 | KYTX Kyverna Therapeutics, Inc. | 387,7 Mio. $ Mid Cap | 6,16 $ | — | — | 37 | Details › |
| 156 | EIKN Eikon Therapeutics, Inc. | 384,0 Mio. $ Mid Cap | 7,51 $ | — | — | 43 | Details › |
| 157 | GALT GALECTIN THERAPEUTICS INC | 383,0 Mio. $ Mid Cap | 3,76 $ | — | — | 62 | Details › |
| 158 | CABA Cabaletta Bio, Inc. | 375,7 Mio. $ Mid Cap | 2,02 $ | — | — | 28 | Details › |
| 159 | ENTA ENANTA PHARMACEUTICALS INC | 374,7 Mio. $ Mid Cap | 12,17 $ | — | — | 45 | Details › |
| 160 | CYPH CYPHERPUNK TECHNOLOGIES INC. | 364,0 Mio. $ Mid Cap | 3,26 $ | 43,3 | — | 32 | Details › |
| 161 | LRMR Larimar Therapeutics, Inc. | 346,8 Mio. $ Mid Cap | 2,78 $ | — | — | 35 | Details › |
| 162 | BNTC Benitec Biopharma Inc. | 346,3 Mio. $ Mid Cap | 9,00 $ | — | — | 46 | Details › |
| 163 | GTBP GT Biopharma, Inc. | 346,2 Mio. $ Mid Cap | 6,37 $ | — | — | 36 | Details › |
| 164 | ARTV Artiva Biotherapeutics, Inc. | 342,4 Mio. $ Mid Cap | 7,27 $ | — | — | 39 | Details › |
| 165 | OCGN Ocugen, Inc. | 325,3 Mio. $ Mid Cap | 1,04 $ | — | — | 37 | Details › |
| 166 | PALI PALISADE BIO, INC. | 325,2 Mio. $ Mid Cap | 1,49 $ | — | — | 50 | Details › |
| 167 | SGMT Sagimet Biosciences Inc. | 318,6 Mio. $ Mid Cap | 8,76 $ | — | — | 45 | Details › |
| 168 | IPSC Century Therapeutics, Inc. | 317,4 Mio. $ Mid Cap | 1,32 $ | — | — | 46 | Details › |
| 169 | BIOA BioAge Labs, Inc. | 312,5 Mio. $ Mid Cap | 6,29 $ | — | — | 51 | Details › |
| 170 | AGEN AGENUS INC | 308,9 Mio. $ Mid Cap | 7,49 $ | — | — | 38 | Details › |
| 171 | NWBO NORTHWEST BIOTHERAPEUTICS INC | 302,9 Mio. $ Mid Cap | 0,15 $ | — | — | 32 | Details › |
| 172 | CYDY CytoDyn Inc. | 300,5 Mio. $ Mid Cap | 0,20 $ | — | — | 32 | Details › |
| 173 | ABEO ABEONA THERAPEUTICS INC. | 299,8 Mio. $ Small Cap | 5,01 $ | 5,0 | — | 51 | Details › |
| 174 | IKT Inhibikase Therapeutics, Inc. | 292,8 Mio. $ Small Cap | 1,98 $ | — | — | 62 | Details › |
| 175 | RCKT ROCKET PHARMACEUTICALS, INC. | 287,7 Mio. $ Small Cap | 2,48 $ | — | — | 42 | Details › |
| 176 | PRLD Prelude Therapeutics Inc | 282,1 Mio. $ Small Cap | 3,81 $ | — | — | 44 | Details › |
| 177 | LAB STANDARD BIOTOOLS INC. | 280,0 Mio. $ Small Cap | 0,72 $ | — | — | 42 | Details › |
| 178 | EPRX EUPRAXIA PHARMACEUTICALS INC. | 277,7 Mio. $ Small Cap | 7,74 $ | — | — | 44 | Details › |
| 179 | SABS SAB Biotherapeutics, Inc. | 277,4 Mio. $ Small Cap | 2,93 $ | — | — | 36 | Details › |
| 180 | ACIU AC Immune SA | 270,5 Mio. $ Small Cap | 2,52 $ | — | — | 48 | Details › |
| 181 | FATE FATE THERAPEUTICS INC | 268,2 Mio. $ Small Cap | 2,29 $ | — | — | 50 | Details › |
| 182 | STRO SUTRO BIOPHARMA, INC. | 262,8 Mio. $ Small Cap | 14,45 $ | — | — | 37 | Details › |
| 183 | CMPX Compass Therapeutics, Inc. | 261,9 Mio. $ Small Cap | 1,00 $ | — | — | 48 | Details › |
| 184 | EVMN Evommune, Inc. | 260,2 Mio. $ Small Cap | 6,44 $ | — | — | 39 | Details › |
| 185 | QTTB Q32 Bio Inc. | 259,6 Mio. $ Small Cap | 8,11 $ | 3,4 | — | 62 | Details › |
| 186 | SION Sionna Therapeutics, Inc. | 259,4 Mio. $ Small Cap | 4,63 $ | — | — | 24 | Details › |
| 187 | UPB Upstream Bio, Inc. | 252,8 Mio. $ Small Cap | 4,77 $ | — | — | 41 | Details › |
| 188 | LXEO Lexeo Therapeutics, Inc. | 251,9 Mio. $ Small Cap | 3,30 $ | — | — | 48 | Details › |
| 189 | BCYC BICYCLE THERAPEUTICS PLC | 247,9 Mio. $ Small Cap | 3,79 $ | — | — | 36 | Details › |
| 190 | LCTX Lineage Cell Therapeutics, Inc. | 245,2 Mio. $ Small Cap | 0,94 $ | — | — | 42 | Details › |
| 191 | LYEL Lyell Immunopharma, Inc. | 238,7 Mio. $ Small Cap | 8,61 $ | — | — | 26 | Details › |
| 192 | TRDA Entrada Therapeutics, Inc. | 237,3 Mio. $ Small Cap | 5,42 $ | — | — | 42 | Details › |
| 193 | NAGE Niagen Bioscience, Inc. | 236,7 Mio. $ Small Cap | 2,69 $ | 14,0 | — | 59 | Details › |
| 194 | KROS Keros Therapeutics, Inc. | 236,1 Mio. $ Small Cap | 11,01 $ | 4,9 | — | 65 | Details › |
| 195 | CAMP Camp4 Therapeutics Corp | 230,5 Mio. $ Small Cap | 3,96 $ | — | — | 37 | Details › |
| 196 | RNAC Cartesian Therapeutics, Inc. | 223,2 Mio. $ Small Cap | 6,75 $ | — | — | 31 | Details › |
| 197 | WHWK Whitehawk Therapeutics, Inc. | 222,2 Mio. $ Small Cap | 3,61 $ | — | — | 60 | Details › |
| 198 | ALXO ALX ONCOLOGY HOLDINGS INC | 219,9 Mio. $ Small Cap | 1,11 $ | — | — | 40 | Details › |
| 199 | YDES YD Bio Ltd | 219,7 Mio. $ Small Cap | 6,37 $ | — | — | 53 | Details › |
| 200 | LIMN Liminatus Pharma, Inc. | 219,3 Mio. $ Small Cap | 3,88 $ | — | — | — | Details › |
| 201 | CGEN COMPUGEN LTD | 212,8 Mio. $ Small Cap | 2,22 $ | 6,1 | — | 53 | Details › |
| 202 | IVA Inventiva S.A. | 200,7 Mio. $ Small Cap | 3,46 $ | — | — | 49 | Details › |
| 203 | PEPG PepGen Inc. | 196,0 Mio. $ Small Cap | 2,31 $ | — | — | 37 | Details › |
| 204 | ORMP ORAMED PHARMACEUTICALS INC. | 194,2 Mio. $ Small Cap | 4,38 $ | 3,0 | 5,4 % | 56 | Details › |
| 205 | NKTX Nkarta, Inc. | 193,9 Mio. $ Small Cap | 2,31 $ | — | — | 49 | Details › |
| 206 | PYXS Pyxis Oncology, Inc. | 187,9 Mio. $ Small Cap | 2,02 $ | — | — | 34 | Details › |
| 207 | TARA Protara Therapeutics, Inc. | 186,5 Mio. $ Small Cap | 2,56 $ | — | — | 43 | Details › |
| 208 | VRXA Veraxa Biotech AG - Post de-SPAC | 183,2 Mio. $ Small Cap | 1,08 $ | — | — | — | Details › |
| 209 | CYCN Korsana Biosciences, Inc. | 181,1 Mio. $ Small Cap | 30,72 $ | — | — | 20 | Details › |
| 210 | PRQR ProQR Therapeutics N.V. | 178,3 Mio. $ Small Cap | 1,65 $ | — | — | 51 | Details › |
| 211 | IMRX Immuneering Corp | 178,3 Mio. $ Small Cap | 3,83 $ | — | — | 39 | Details › |
| 212 | QSI Quantum-Si Inc | 175,8 Mio. $ Small Cap | 1,22 $ | — | — | 35 | Details › |
| 213 | NBP NovaBridge Biosciences | 172,8 Mio. $ Small Cap | 1,40 $ | — | — | 33 | Details › |
| 214 | ABOS Acumen Pharmaceuticals, Inc. | 169,7 Mio. $ Small Cap | 2,03 $ | — | — | 49 | Details › |
| 215 | KRRO Korro Bio, Inc. | 166,7 Mio. $ Small Cap | 9,76 $ | — | — | 35 | Details › |
| 216 | NAUT Nautilus Biotechnology, Inc. | 166,3 Mio. $ Small Cap | 1,77 $ | — | — | 43 | Details › |
| 217 | CDXS CODEXIS, INC. | 165,1 Mio. $ Small Cap | 1,36 $ | — | — | 39 | Details › |
| 218 | ARMP Armata Pharmaceuticals, Inc. | 164,3 Mio. $ Small Cap | 3,85 $ | — | — | 44 | Details › |
| 219 | ADCT ADC Therapeutics SA | 161,8 Mio. $ Small Cap | 1,27 $ | — | — | 43 | Details › |
| 220 | SPRB SPRUCE BIOSCIENCES, INC. | 160,2 Mio. $ Small Cap | 42,79 $ | — | — | 36 | Details › |
| 221 | DTIL PRECISION BIOSCIENCES INC | 159,9 Mio. $ Small Cap | 6,20 $ | — | — | 37 | Details › |
| 222 | IPHA Innate Pharma SA | 158,4 Mio. $ Small Cap | 1,59 $ | — | — | — | Details › |
| 223 | VYGR Voyager Therapeutics, Inc. | 157,7 Mio. $ Small Cap | 2,46 $ | — | — | 29 | Details › |
| 224 | RANI Rani Therapeutics Holdings, Inc. | 157,2 Mio. $ Small Cap | 0,83 $ | — | — | 59 | Details › |
| 225 | RNA Atrium Therapeutics, Inc. | 153,5 Mio. $ Small Cap | 8,01 $ | — | — | 58 | Details › |
| 226 | CLLS Cellectis S.A. | 152,4 Mio. $ Small Cap | 1,40 $ | — | — | 30 | Details › |
| 227 | FHTX Foghorn Therapeutics Inc. | 148,0 Mio. $ Small Cap | 1,97 $ | — | — | 21 | Details › |
| 228 | CURX Curanex Pharmaceuticals Inc | 141,9 Mio. $ Small Cap | 4,99 $ | — | — | — | Details › |
| 229 | TNYA Tenaya Therapeutics, Inc. | 136,1 Mio. $ Small Cap | 0,55 $ | — | — | 32 | Details › |
| 230 | CRBU Caribou Biosciences, Inc. | 135,2 Mio. $ Small Cap | 1,14 $ | — | — | 15 | Details › |
| 231 | AGPU Axe Compute Inc. | 128,4 Mio. $ Small Cap | 12,29 $ | — | — | 38 | Details › |
| 232 | IMUX IMMUNIC, INC. | 127,9 Mio. $ Small Cap | 7,82 $ | — | — | 29 | Details › |
| 233 | HURA TuHURA Biosciences, Inc./NV | 125,6 Mio. $ Small Cap | 1,95 $ | — | — | 43 | Details › |
| 234 | CRBP Corbus Pharmaceuticals Holdings, Inc. | 124,8 Mio. $ Small Cap | 5,78 $ | — | — | 43 | Details › |
| 235 | ENGN enGene Therapeutics Inc. | 122,3 Mio. $ Small Cap | 1,80 $ | 0,8 | — | 26 | Details › |
| 236 | SEER Seer, Inc. | 120,5 Mio. $ Small Cap | 2,19 $ | — | — | 56 | Details › |
| 237 | OKUR OnKure Therapeutics, Inc. | 120,4 Mio. $ Small Cap | 2,46 $ | — | — | 54 | Details › |
| 238 | UNCY Unicycive Therapeutics, Inc. | 119,2 Mio. $ Small Cap | 4,23 $ | — | — | 21 | Details › |
| 239 | GNLX GENELUX Corp | 118,7 Mio. $ Small Cap | 2,54 $ | — | — | 49 | Details › |
| 240 | ADAG Adagene Inc. | 115,3 Mio. $ Small Cap | 2,93 $ | — | — | 55 | Details › |
| 241 | COYA Coya Therapeutics, Inc. | 114,4 Mio. $ Small Cap | 4,85 $ | — | — | 63 | Details › |
| 242 | MXCT MAXCYTE, INC. | 112,1 Mio. $ Small Cap | 1,09 $ | — | — | 58 | Details › |
| 243 | VXRT Vaxart, Inc. | 111,9 Mio. $ Small Cap | 0,42 $ | 6,0 | — | 65 | Details › |
| 244 | PLYX Polaryx Therapeutics, Inc. | 110,6 Mio. $ Small Cap | 2,10 $ | — | — | — | Details › |
| 245 | INO INOVIO PHARMACEUTICALS, INC. | 107,7 Mio. $ Small Cap | 1,13 $ | — | — | 23 | Details › |
| 246 | EQ Equillium, Inc. | 107,6 Mio. $ Small Cap | 1,42 $ | — | — | 50 | Details › |
| 247 | NTRB NutriBand Inc. | 106,2 Mio. $ Small Cap | 6,68 $ | — | — | 52 | Details › |
| 248 | NMRA Neumora Therapeutics, Inc. | 105,9 Mio. $ Small Cap | 0,47 $ | — | — | 20 | Details › |
| 249 | BDTX Black Diamond Therapeutics, Inc. | 105,8 Mio. $ Small Cap | 1,80 $ | 4,8 | — | 61 | Details › |
| 250 | PMN ProMIS Neurosciences Inc. | 102,4 Mio. $ Small Cap | 9,21 $ | — | — | 44 | Details › |
| 251 | CGTX COGNITION THERAPEUTICS INC | 97,3 Mio. $ Small Cap | 0,94 $ | — | — | 60 | Details › |
| 252 | MNOV MEDICINOVA INC | 96,2 Mio. $ Small Cap | 1,65 $ | — | — | 31 | Details › |
| 253 | ATRA Atara Biotherapeutics, Inc. | 94,7 Mio. $ Small Cap | 9,75 $ | 3,7 | — | 45 | Details › |
| 254 | ANIX Anixa Biosciences Inc | 93,4 Mio. $ Small Cap | 3,02 $ | — | — | 53 | Details › |
| 255 | CRDF Cardiff Oncology, Inc. | 93,2 Mio. $ Small Cap | 1,07 $ | — | — | 47 | Details › |
| 256 | RLYB Rallybio Corp | 92,7 Mio. $ Small Cap | 17,08 $ | — | — | 61 | Details › |
| 257 | PROK PROKIDNEY CORP. | 91,9 Mio. $ Small Cap | 1,60 $ | — | — | 35 | Details › |
| 258 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | 90,7 Mio. $ Small Cap | 2,97 $ | — | — | 34 | Details › |
| 259 | PYPD PolyPid Ltd. | 90,5 Mio. $ Small Cap | 5,13 $ | — | — | 57 | Details › |
| 260 | ONCY ONCOLYTICS BIOTECH INC | 89,3 Mio. $ Small Cap | 0,60 $ | — | — | 35 | Details › |
| 261 | LEXX Lexaria Bioscience Corp. | 86,4 Mio. $ Small Cap | 3,24 $ | — | — | 19 | Details › |
| 262 | TLSA Tiziana Life Sciences Ltd | 85,2 Mio. $ Small Cap | 1,11 $ | — | — | 50 | Details › |
| 263 | RNXT RenovoRx, Inc. | 80,0 Mio. $ Small Cap | 1,39 $ | — | — | 42 | Details › |
| 264 | GANX Gain Therapeutics, Inc. | 77,6 Mio. $ Small Cap | 1,67 $ | — | — | 59 | Details › |
| 265 | MAIA MAIA Biotechnology, Inc. | 77,5 Mio. $ Small Cap | 1,19 $ | — | — | 55 | Details › |
| 266 | OSTX OS Therapies Inc | 76,1 Mio. $ Small Cap | 1,49 $ | — | — | 39 | Details › |
| 267 | CING Cingulate Inc. | 74,4 Mio. $ Small Cap | 4,89 $ | — | — | 48 | Details › |
| 268 | IBIO iBio, Inc. | 72,7 Mio. $ Small Cap | 1,05 $ | — | — | 47 | Details › |
| 269 | CSBR CHAMPIONS ONCOLOGY, INC. | 72,5 Mio. $ Small Cap | 5,01 $ | — | — | — | Details › |
| 270 | PLRX PLIANT THERAPEUTICS, INC. | 72,2 Mio. $ Small Cap | 1,03 $ | — | — | 36 | Details › |
| 271 | RFL Rafael Holdings, Inc. | 71,0 Mio. $ Small Cap | 1,49 $ | — | — | 45 | Details › |
| 272 | GUTS FRACTYL HEALTH, INC. | 70,2 Mio. $ Small Cap | 4,57 $ | — | — | 45 | Details › |
| 273 | FBIO Fortress Biotech, Inc. | 68,7 Mio. $ Small Cap | 2,05 $ | — | — | 43 | Details › |
| 274 | KLRS Kalaris Therapeutics, Inc. | 66,9 Mio. $ Small Cap | 2,66 $ | — | — | 46 | Details › |
| 275 | XBIT XBiotech Inc. | 66,5 Mio. $ Small Cap | 2,16 $ | — | — | — | Details › |
| 276 | LNAI Lunai Bioworks Inc. | 65,2 Mio. $ Small Cap | 1,13 $ | — | — | — | Details › |
| 277 | ANVS Annovis Bio, Inc. | 60,7 Mio. $ Small Cap | 1,18 $ | — | — | 27 | Details › |
| 278 | INKT MiNK Therapeutics, Inc. | 60,4 Mio. $ Small Cap | 11,70 $ | — | — | 60 | Details › |
| 279 | XLO Xilio Therapeutics, Inc. | 59,8 Mio. $ Small Cap | 9,00 $ | — | — | — | Details › |
| 280 | INMB Inmune Bio, Inc. | 59,5 Mio. $ Small Cap | 1,87 $ | — | — | 55 | Details › |
| 281 | BRTX BioRestorative Therapies, Inc. | 59,4 Mio. $ Small Cap | 2,27 $ | — | — | — | Details › |
| 282 | ALDX Aldeyra Therapeutics, Inc. | 57,7 Mio. $ Small Cap | 0,92 $ | — | — | 37 | Details › |
| 283 | CALC CalciMedica, Inc. | 56,8 Mio. $ Small Cap | 1,49 $ | — | — | — | Details › |
| 284 | BOLD Boundless Bio, Inc. | 56,2 Mio. $ Small Cap | 2,57 $ | — | — | 64 | Details › |
| 285 | ELTX Elicio Therapeutics, Inc. | 55,8 Mio. $ Small Cap | 1,88 $ | — | — | 30 | Details › |
| 286 | HYFT MindWalk Holdings Corp. | 55,6 Mio. $ Small Cap | 1,55 $ | — | — | 59 | Details › |
| 287 | BIAF bioAffinity Technologies, Inc. | 55,3 Mio. $ Small Cap | 6,06 $ | — | — | 24 | Details › |
| 288 | IBO IMPACT BIOMEDICAL INC. | 55,2 Mio. $ Small Cap | 4,68 $ | — | — | — | Details › |
| 289 | DWTX Dogwood Therapeutics, Inc. | 54,5 Mio. $ Small Cap | 1,52 $ | — | — | 28 | Details › |
| 290 | SER Serina Therapeutics, Inc. | 54,2 Mio. $ Small Cap | 2,02 $ | — | — | — | Details › |
| 291 | LONA LeonaBio, Inc. | 53,7 Mio. $ Small Cap | 5,75 $ | — | — | 45 | Details › |
| 292 | IMA ImageneBio, Inc. | 53,5 Mio. $ Small Cap | 4,60 $ | — | — | — | Details › |
| 293 | APLM Apollomics Inc. | 53,1 Mio. $ Small Cap | 22,10 $ | — | — | — | Details › |
| 294 | HOWL Werewolf Therapeutics, Inc. | 52,3 Mio. $ Small Cap | 0,92 $ | — | — | 38 | Details › |
| 295 | OKYO OKYO Pharma Ltd | 51,9 Mio. $ Small Cap | 1,46 $ | — | — | 49 | Details › |
| 296 | EXOZ EXOZYMES INC. | 51,2 Mio. $ Small Cap | 5,52 $ | — | — | — | Details › |
| 297 | ACET Adicet Bio, Inc. | 50,3 Mio. $ Small Cap | 6,25 $ | — | — | 29 | Details › |
| 298 | TIL Instil Bio, Inc. | 50,1 Mio. $ Small Cap | 6,89 $ | — | — | — | Details › |
| 299 | HRTX HERON THERAPEUTICS, INC. /DE/ | 49,7 Mio. $ Micro Cap | 0,33 $ | — | — | 30 | Details › |
| 300 | CELU Celularity Inc | 48,6 Mio. $ Micro Cap | 1,58 $ | — | — | 39 | Details › |
| 301 | BSEM BioStem Technologies, Inc. | 47,2 Mio. $ Micro Cap | 2,47 $ | — | — | — | Details › |
| 302 | SCYX SCYNEXIS INC | 45,4 Mio. $ Micro Cap | 4,84 $ | — | — | 46 | Details › |
| 303 | BYSI BeyondSpring Inc. | 45,2 Mio. $ Micro Cap | 0,69 $ | — | — | — | Details › |
| 304 | CRVO CervoMed Inc. | 45,0 Mio. $ Micro Cap | 3,34 $ | — | — | 46 | Details › |
| 305 | TCRX TScan Therapeutics, Inc. | 43,8 Mio. $ Micro Cap | 0,28 $ | — | — | 17 | Details › |
| 306 | LITS Lite Strategy, Inc. | 43,2 Mio. $ Micro Cap | 1,41 $ | — | 123,2 % | 40 | Details › |
| 307 | VERU VERU INC. | 43,2 Mio. $ Micro Cap | 2,47 $ | — | 8,3 % | 55 | Details › |
| 308 | MCRB Seres Therapeutics, Inc. | 39,4 Mio. $ Micro Cap | 2,90 $ | 4,6 | — | 51 | Details › |
| 309 | MGX Metagenomi Therapeutics, Inc. | 38,0 Mio. $ Micro Cap | 1,03 $ | — | — | 34 | Details › |
| 310 | BCTX BriaCell Therapeutics Corp. | 37,8 Mio. $ Micro Cap | 4,02 $ | — | — | 45 | Details › |
| 311 | ALGS Aligos Therapeutics, Inc. | 33,1 Mio. $ Micro Cap | 5,38 $ | — | — | 33 | Details › |
| 312 | CVM CEL SCI CORP | 31,1 Mio. $ Micro Cap | 2,74 $ | — | — | 47 | Details › |
| 313 | ARTL ARTELO BIOSCIENCES, INC. | 30,4 Mio. $ Micro Cap | 3,46 $ | — | — | 27 | Details › |
| 314 | BRNS Barinthus Biotherapeutics plc. | 30,2 Mio. $ Micro Cap | 0,74 $ | — | — | — | Details › |
| 315 | GRDX GridAI Technologies Corp. | 30,0 Mio. $ Micro Cap | 4,17 $ | — | — | 38 | Details › |
| 316 | TAOX TAO Synergies Inc. | 29,8 Mio. $ Micro Cap | 4,56 $ | — | — | 51 | Details › |
| 317 | RNAZ Transcode Therapeutics, Inc. | 29,2 Mio. $ Micro Cap | 1,78 $ | — | — | — | Details › |
| 318 | TVGN Tevogen Inc. | 27,4 Mio. $ Micro Cap | 6,49 $ | — | — | — | Details › |
| 319 | NXTC NextCure, Inc. | 26,4 Mio. $ Micro Cap | 5,69 $ | — | — | 28 | Details › |
| 320 | ACTU ACTUATE THERAPEUTICS, INC. | 25,7 Mio. $ Micro Cap | 0,81 $ | — | — | 28 | Details › |
| 321 | PDSB PDS Biotechnology Corp | 25,2 Mio. $ Micro Cap | 1,05 $ | — | — | 10 | Details › |
| 322 | QNTM Quantum Biopharma Ltd. | 23,5 Mio. $ Micro Cap | 3,09 $ | — | — | 43 | Details › |
| 323 | TVRD Tvardi Therapeutics, Inc. | 23,3 Mio. $ Micro Cap | 1,08 $ | — | — | 30 | Details › |
| 324 | COCP Cocrystal Pharma, Inc. | 22,4 Mio. $ Micro Cap | 1,11 $ | — | — | — | Details › |
| 325 | ATOS ATOSSA THERAPEUTICS, INC. | 20,6 Mio. $ Micro Cap | 2,45 $ | — | — | 39 | Details › |
| 326 | EVAX Evaxion A/S | 19,6 Mio. $ Micro Cap | 3,16 $ | — | — | 50 | Details › |
| 327 | NEUP Neuphoria Therapeutics Inc. | 19,5 Mio. $ Micro Cap | 3,45 $ | — | — | — | Details › |
| 328 | DYAI DYADIC INTERNATIONAL INC | 19,2 Mio. $ Micro Cap | 0,45 $ | — | — | — | Details › |
| 329 | MRKR Marker Therapeutics, Inc. | 18,7 Mio. $ Micro Cap | 1,01 $ | — | — | — | Details › |
| 330 | LPCN Lipocine Inc. | 18,2 Mio. $ Micro Cap | 2,10 $ | — | — | — | Details › |
| 331 | ALLR Allarity Therapeutics, Inc. | 17,2 Mio. $ Micro Cap | 0,99 $ | — | — | 39 | Details › |
| 332 | JSPR Jasper Therapeutics, Inc. | 17,1 Mio. $ Micro Cap | 0,56 $ | — | — | 5 | Details › |
| 333 | GNTA Genenta Science S.p.A. | 16,8 Mio. $ Micro Cap | 0,78 $ | — | — | — | Details › |
| 334 | KZIA KAZIA THERAPEUTICS LTD | 16,0 Mio. $ Micro Cap | 9,26 $ | — | — | 40 | Details › |
| 335 | KTTA Pasithea Therapeutics Corp. | 15,8 Mio. $ Micro Cap | 0,45 $ | — | — | — | Details › |
| 336 | CMMB Chemomab Therapeutics Ltd. | 15,6 Mio. $ Micro Cap | 1,40 $ | 11,8 | — | 36 | Details › |
| 337 | BCDA BioCardia, Inc. | 15,1 Mio. $ Micro Cap | 1,06 $ | — | — | 51 | Details › |
| 338 | PASG Passage BIO, Inc. | 14,6 Mio. $ Micro Cap | 4,08 $ | — | — | — | Details › |
| 339 | VTGN Vistagen Therapeutics, Inc. | 14,3 Mio. $ Micro Cap | 0,25 $ | — | — | 37 | Details › |
| 340 | LSTA LISATA THERAPEUTICS, INC. | 13,7 Mio. $ Micro Cap | 1,21 $ | — | — | — | Details › |
| 341 | BIVI BIOVIE INC. | 12,8 Mio. $ Micro Cap | 1,44 $ | — | — | 42 | Details › |
| 342 | PLRZ Polyrizon Ltd. | 12,4 Mio. $ Micro Cap | 9,67 $ | — | — | — | Details › |
| 343 | AZTR Azitra, Inc. | 11,9 Mio. $ Micro Cap | 0,13 $ | — | — | 40 | Details › |
| 344 | LTRN Lantern Pharma Inc. | 11,9 Mio. $ Micro Cap | 0,95 $ | — | — | 13 | Details › |
| 345 | XBIO Xenetic Biosciences, Inc. | 11,7 Mio. $ Micro Cap | 2,12 $ | — | — | 26 | Details › |
| 346 | TOVX Theriva Biologics, Inc. | 11,0 Mio. $ Micro Cap | 0,22 $ | — | — | — | Details › |
| 347 | DARE Dare Bioscience, Inc. | 10,9 Mio. $ Micro Cap | 0,83 $ | — | — | 19 | Details › |
| 348 | MTVA MetaVia Inc. | 10,8 Mio. $ Micro Cap | 1,48 $ | — | — | — | Details › |
| 349 | INTS INTENSITY THERAPEUTICS, INC. | 10,7 Mio. $ Micro Cap | 3,55 $ | — | — | — | Details › |
| 350 | MSLE Satellos Bioscience Inc. | 10,4 Mio. $ Micro Cap | 7,54 $ | — | — | 59 | Details › |
| 351 | NRSN NeuroSense Therapeutics Ltd. | 9,9 Mio. $ Micro Cap | 4,07 $ | — | — | — | Details › |
| 352 | FBLG FibroBiologics, Inc. | 9,6 Mio. $ Micro Cap | 1,13 $ | — | — | 31 | Details › |
| 353 | SNTI Senti Biosciences Holdings, Inc. | 9,4 Mio. $ Micro Cap | 0,32 $ | — | — | 23 | Details › |
| 354 | MDCX Medicus Pharma Ltd. | 9,3 Mio. $ Micro Cap | 0,16 $ | — | — | 33 | Details › |
| 355 | APRE Aprea Therapeutics, Inc. | 9,2 Mio. $ Micro Cap | 0,64 $ | — | — | 36 | Details › |
| 356 | MBRX Moleculin Biotech, Inc. | 9,1 Mio. $ Micro Cap | 0,45 $ | — | — | 15 | Details › |
| 357 | NCNA NuCana plc | 8,5 Mio. $ Micro Cap | 1,09 $ | — | — | — | Details › |
| 358 | ENLV Enlivex Ltd. | 8,3 Mio. $ Micro Cap | 0,34 $ | 0,0 | — | 23 | Details › |
| 359 | SNGX SOLIGENIX, INC. | 8,3 Mio. $ Micro Cap | 0,36 $ | — | — | — | Details › |
| 360 | ALZN Alzamend Neuro, Inc. | 7,8 Mio. $ Micro Cap | 1,37 $ | — | — | 36 | Details › |
| 361 | KALA KALA BIO, Inc. | 7,5 Mio. $ Micro Cap | 0,36 $ | — | — | 17 | Details › |
| 362 | INM InMed Pharmaceuticals Inc. | 7,5 Mio. $ Micro Cap | 1,33 $ | — | — | — | Details › |
| 363 | IMRN Immuron Ltd | 7,1 Mio. $ Micro Cap | 1,08 $ | — | — | — | Details › |
| 364 | IMNN Imunon, Inc. | 7,1 Mio. $ Micro Cap | 1,12 $ | — | — | 22 | Details › |
| 365 | BOLT Bolt Biotherapeutics, Inc. | 7,1 Mio. $ Micro Cap | 3,51 $ | — | — | — | Details › |
| 366 | CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | 6,4 Mio. $ Micro Cap | 0,90 $ | — | — | 30 | Details › |
| 367 | BGMS Bio Green Med Solution, Inc. | 6,0 Mio. $ Micro Cap | 0,86 $ | — | — | — | Details › |
| 368 | INBS INTELLIGENT BIO SOLUTIONS INC. | 5,5 Mio. $ Micro Cap | 1,58 $ | — | — | — | Details › |
| 369 | PULM Pulmatrix, Inc. | 5,4 Mio. $ Micro Cap | 1,43 $ | — | — | — | Details › |
| 370 | CLGN CollPlant Biotechnologies Ltd | 4,8 Mio. $ Micro Cap | 3,39 $ | — | — | 31 | Details › |
| 371 | ERNA Ernexa Therapeutics Inc. | 4,6 Mio. $ Micro Cap | 2,24 $ | — | — | — | Details › |
| 372 | PMCB PharmaCyte Biotech, Inc. | 4,6 Mio. $ Micro Cap | 0,42 $ | — | — | — | Details › |
| 373 | GLMD Galmed Pharmaceuticals Ltd. | 4,6 Mio. $ Micro Cap | 3,45 $ | — | — | — | Details › |
| 374 | PCSA Processa Pharmaceuticals, Inc. | 4,3 Mio. $ Micro Cap | 1,52 $ | — | — | — | Details › |
| 375 | GRI GRI Bio, Inc. | 4,1 Mio. $ Micro Cap | 1,90 $ | — | — | 37 | Details › |
| 376 | HCWB HCW Biologics Inc. | 3,8 Mio. $ Micro Cap | 1,57 $ | — | — | 5 | Details › |
| 377 | MLEC Moolec Science SA | 3,6 Mio. $ Micro Cap | 4,83 $ | — | — | — | Details › |
| 378 | VIVS VivoSim Labs, INC. | 3,4 Mio. $ Micro Cap | 0,20 $ | — | — | 4 | Details › |
| 379 | CLDI Calidi Biotherapeutics, Inc. | 3,4 Mio. $ Micro Cap | 1,02 $ | — | — | — | Details › |
| 380 | APVO Aptevo Therapeutics Inc. | 3,2 Mio. $ Micro Cap | 1,80 $ | — | — | — | Details › |
| 381 | ADXN Addex Therapeutics Ltd. | 3,1 Mio. $ Micro Cap | 3,18 $ | — | — | — | Details › |
| 382 | CANF Can-Fite BioPharma Ltd. | 2,9 Mio. $ Micro Cap | 2,14 $ | — | — | — | Details › |
| 383 | TCRT Alaunos Therapeutics, Inc. | 2,8 Mio. $ Micro Cap | 0,74 $ | — | — | 16 | Details › |
| 384 | SLXN Silexion Therapeutics Corp | 2,7 Mio. $ Micro Cap | 0,26 $ | 0,0 | — | 1 | Details › |
| 385 | SBFM Sunshine Biopharma Inc. | 2,7 Mio. $ Micro Cap | 0,40 $ | — | — | 20 | Details › |
| 386 | GOVX GeoVax Labs, Inc. | 2,6 Mio. $ Micro Cap | 0,29 $ | — | — | — | Details › |
| 387 | GNPX Genprex, Inc. | 2,5 Mio. $ Micro Cap | 2,61 $ | — | — | 23 | Details › |
| 388 | SILO Silo Pharma, Inc. | 2,5 Mio. $ Micro Cap | 1,45 $ | — | — | — | Details › |
| 389 | CRIS CURIS INC | 1,8 Mio. $ Micro Cap | 0,75 $ | — | — | 16 | Details › |
| 390 | DCOY Decoy Therapeutics Inc. | 1,1 Mio. $ Micro Cap | 1,55 $ | — | — | 14 | Details › |
| 391 | STKH Steakholder Foods Ltd. | 966.082 $ Micro Cap | 0,65 $ | — | — | — | Details › |
| 392 | RKDA Arcadia Biosciences, Inc. | 650.410 $ Micro Cap | 0,30 $ | — | — | 23 | Details › |
| 393 | BDRX Biodexa Pharmaceuticals Plc | 520.425 $ Micro Cap | 0,60 $ | — | — | 22 | Details › |
| 394 | XRTX XORTX Therapeutics Inc. | 486.835 $ Micro Cap | 1,73 $ | — | — | — | Details › |
| 395 | VRAX Virax Biolabs Group Ltd | 436.818 $ Micro Cap | 2,03 $ | — | — | — | Details › |
| 396 | SPRC SciSparc Ltd. | 311.625 $ Micro Cap | 4,33 $ | — | — | — | Details › |
| 397 | PPBT PURPLE BIOTECH LTD. | 220.866 $ Micro Cap | 1,47 $ | — | — | — | Details › |
| 398 | CDT CDT Equity Inc. | 81.172 $ Micro Cap | 0,93 $ | — | — | -3 | Details › |
| 399 | ADTX Aditxt, Inc. | 3.823 $ Micro Cap | 0,00 $ | — | — | — | Details › |